Toll Free: 1-888-928-9744

Organogenesis, Inc. - Product Pipeline Analysis, 2016 Update

Published: Mar 30, 2016 | Pages: 29 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Organogenesis, Inc. (Organogenesis) is a regenerative medicine company that concentrates on bioactive wound healing and soft tissue regeneration. The company's products include Apligraf and Dermagraft. Its Dermagraft is used for the treatment of full-thickness diabetic foot ulcers which are greater than 6 weeks duration. Organogenesis's Apligraf is used for the treatment of venous leg ulcers and diabetic foot ulcers.  Its Dermagraft is indicated in conjunction with standard wound care regimens in patients with adequate blood supply to the involved foot. The company serves the areas of bio-active wound healing, oral regeneration and bio-surgery. Organogenesis is headquartered in Canton, Massachusetts, the US. 

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Organogenesis, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents 
Table of Contents 2
List of Tables  3
List of Figures  4
Organogenesis, Inc. Company Snapshot  5
Organogenesis, Inc. Company Overview  5
Organogenesis, Inc. Pipeline Products and Clinical Trials Overview  6
Organogenesis, Inc. - Pipeline Analysis Overview  8
Key Facts  8
Organogenesis, Inc. - Major Products and Services  9
Organogenesis, Inc. Pipeline Products by Development Stage  10
Organogenesis, Inc. Pipeline Products Overview  12
Dermagraft - Epidermolysis Bullosa  12
Dermagraft - Epidermolysis Bullosa Product Overview  12
Dermagraft - Rotator Cuff Repair  13
Dermagraft - Rotator Cuff Repair Product Overview  13
Dermagraft - Venous Leg Ulcers Repair  14
Dermagraft - Venous Leg Ulcers Repair Product Overview  14
VCT01  15
VCT01 Product Overview  15
Organogenesis, Inc. - Key Competitors  16
Organogenesis, Inc. - Key Employees  17
Organogenesis, Inc. - Locations And Subsidiaries  18
Head Office  18
Other Locations & Subsidiaries  18
Recent Developments  19
Organogenesis, Inc., Recent Developments  19
Nov 02, 2015: Apligraf Wound Healing Technology Becomes First Transplant Product to Receive Marketing Approval in Switzerland  19
Oct 08, 2015: Comparative Effectiveness Analyses Report Faster Healing Times, Improved Probability of Chronic Wound Closure with Apligraf and Dermagraft  20
Jul 22, 2015: Organogenesis Launches New PuraPly Products at the APMA 2015 Annual Scientific Meeting  20
Jun 22, 2015: Landmark New Data: Apligraf Closes Significantly More Diabetic Foot Ulcers in Half the Time When Compared to Epifix  21
Mar 26, 2015: Journal of Medical Economics Publishes Findings from Groundbreaking Research Demonstrating the Health Economic Benefits of Apligraf and Dermagraft  22
Feb 04, 2015: Organogenesis Announces MiMedx Has Dismissed its Frivolous Lawsuit  23
Dec 31, 2014: MiMedx Files Tortious Interference Lawsuit Against Organogenesis  24
Apr 30, 2014: Organogenesis to Present Large Retrospective Comparative Effectiveness Analysis and Health Economic Data in Chronic Wound Healing at The Symposium on Advanced Wound Care and Wound Healing Society Meeting  25
Apr 22, 2014: Organogenesis to Present New Dermagraft Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting  26
Apr 22, 2014: Organogenesis to Present New Apligraf Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting  27
Appendix  29
Methodology  29
About GlobalData  29
Contact Us  29
Disclaimer  29
List of Tables
Organogenesis, Inc. Pipeline Products and Clinical Trials Overview  6
Organogenesis, Inc. Pipeline Products by Equipment Type  6
Organogenesis, Inc. Pipeline Products by Indication  7
Organogenesis, Inc., Key Facts  8
Organogenesis, Inc., Major Products and Services  9
Organogenesis, Inc. Number of Pipeline Products by Development Stage  10
Organogenesis, Inc. Pipeline Products Summary by Development Stage  11
Dermagraft - Epidermolysis Bullosa - Product Status  12
Dermagraft - Epidermolysis Bullosa - Product Description  12
Dermagraft - Rotator Cuff Repair - Product Status  13
Dermagraft - Rotator Cuff Repair - Product Description  13
Dermagraft - Venous Leg Ulcers Repair - Product Status  14
Dermagraft - Venous Leg Ulcers Repair - Product Description  14
VCT01 - Product Status  15
VCT01 - Product Description  15
Organogenesis, Inc., Key Employees  17
Organogenesis, Inc., Other Locations  18
Organogenesis, Inc., Subsidiaries  18 


List of Figures
Organogenesis, Inc. Pipeline Products by Equipment Type  7
Organogenesis, Inc. Pipeline Products by Development Stage  10

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify